A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice

By Katz J.J.M.   Lu X.   Todd C.W.C.W.   Newman M.J.M.J.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2177-2187

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

By Minutello M.   Senatore F.   Cecchinelli G.   Bianchi M.   Andreani T.   Podda A.   Crovari P.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax(R))

By Cho H.-W.   Howard C.R.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2569-2575

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience

By Pittman P.R.   Liu C.T.   Cannon T.L.   Makuch R.S.   Mangiafico J.A.   Gibbs P.H.   Peters C.J.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 181-189

Elsevier

Access to resources Recommend Favorite